Cytomegalovirus (CMV) was shown to induce a state of viral interference in human embryo fibroblast cultures (HEF). This interference was characterized by: (i) requirement for infectious virus; (ii) a latent period (48 to 96 h) for establishment of the interference; (iii) activity against a representative group of heterologous viruses; (iv) loss of interfering activity when challenged with a high multiplicity of infection; (v) 
mediator shares a number of characteristics with interferon. This state of interference in HEF cultures could be simulated by extended exposure to subdetectable levels of human interferon. It is postulated that CMV induced the production of a soluble, interferon-like mediator of viral interference and that continuous exposure of the HEF culture to this mediator resulted in the development of resistance to a number of heterologous viruses.
Infection with cytomegalovirus (CMV) has been characterized by the lack of induction of interferon both in vivo and in vitro (3, 7, 8) . In subsequent experiments it was observed that human embryo fibroblast cultures (HEF) infected with CMV were resistant to superinfection with vesicular stomatitis virus (VSV). This finding was unexpected, but provided the opportunity to elucidate the nature of what appeared initially to be an example of noninterferon-mediated interference.
MATERIALS AND METHODS Virus. The AD 169 strain of CMV was maintained by passage in HEF cultures. Newcastle Disease Virus (NDV), Herts strain, was propagated in embryonated hen eggs. Herpesvirus hominis (HVH) and vaccinia virus were grown in primary mouse embryo fibroblasts, and echovirus type 11 was a human isolate used for rubella identification by the Monroe County (N.Y.) Health Department Virology Laboratory. Stocks of VSV, Indiana strain, and encephalomyocarditis (EMC) virus were prepared in L cells, and Sindbis virus was used as a 10% homogenate of infected mouse brains.
Cell cultures. The HEF cultures were either a continuous line of human embryo lung obtained from David Lang, Duke University School of Medicine, or a continuous line of human embryo skin prepared in our laboratory from a spontaneous abortion. All cultures were maintained in Eagle minimum essential medium (MEM) with double concentration of amino acids and vitamins and 10% fetal calf serum.
Interferon. Interferon was assayed by the plaque reduction method in HEF cells with Sindbis virus or VSV as the challenge agent. A unit of interferon is expressed as the reciprocal of the dilution that produces a 50% reduction in plaques as compared with control cultures. The preparation of human interferon utilized in these experiments was prepared in human leukocytes exposed to NDV and contained 160 to 250 U of interferon per ml. RESULTS CMV interference. Initially it was observed that cultures of HEF infected with CMV were resistant to superinfection with VSV. Interferon activity could not be detected in medium collected from CMV-infected cultures at the time that interference could be demonstrated in these cultures. These initial observations suggested that a form of noninterferonmediated interference was occurring in cultures of HEF infected with CMV.
Characteristics of CMV interference. Interference with VSV or Sindbis virus was used as a model system to delineate the mechanism of observed interference in CMV-infected cultures. Interference could be demonstrated either by the plaque reduction method or by inhibition of viral replication. The establishment of interference required 48 to 96 h, depending upon the inoculum size of CMV, and usually was not manifested until the appearance of the characteristic foci of CPE caused by CMV in infected cultures. The time for establishment of interference in replicate cultures of HEF after infection with CMV is illustrated in Fig. 1 .
The observation that a period of time is required for establishment of interference suggested that either viral replication or production of a mediator of interference is necessary for cultures to become resistant to superinfection. In the absence of detectable levels of interferon, it was postulated that a majority of cells in the culture had to be infected with progeny CMV, or, alternatively, that either a component of CMV or some other virus-associated product of the CMV-cell interaction functioned as the mediator of interference. It would seem reasonable that a period of time would be required for production and dissemination of this substance to the entire cell population.
To determine if the establishment of interference could be prevented by neutralization of the CMV inoculum with specific neutralizing antibody, 0.2 ml of undiluted supernatant harvested from a CMV-infected culture after three freeze-thaw cycles was incubated for 0.5 h with an equal volume of human anti-CMV antiserum prior to inoculation of HEF cultures. The neutralization of CMV and prevention of the development of CPE by antibody was associated with failure to establish interference. In addition, inoculation of a culture of HEF with a heatinactivated CMV preparation also failed to establish interference. These results support the interpretation that an antiviral substance was not present in the original inoculum and that viral multiplication was necessary for establishment of interference.
Because of the observation that once a plaque (VSV) was established in a CMV-infected culture it continued to enlarge, the effect of input multiplicity of infection on the interference was determined. CMV interference could be overcome with an increasing multiplicity of infection. Similarly, a breakthrough in interference was observed after a low initial input multiplicity after 3 to 6 days. The results from one representative experiment illustrating this phenomenon are summarized in Fig. 2 . These data indicate that the population of cells in the CMV-infected culture that appeared to be resistant to superinfection are, in fact, capable of supporting replication of VSV.
To rule out the possibility that the interference was associated with an effect on receptor sites, the rate of adsorption of virus to cells in CMV-infected and control HEF cultures was determined. An inoculum of 1.6 ml containing 2 x 105 PFU of VSV per ml was added to 60-mm petri dishes, and 0. A series of experiments were then designed to determine if a soluble mediator of CMV interference could be detected. As noted, CMV-neutralizing antibody prevented the development of CMV-CPE and the establishment of interference when mixed with the CMV inoculum prior to addition to the cultures. Since CMV has the capacity to spread cell-to-cell, we postulated that CMV-neutralizing antibody added after adsorption of CMV would not prevent the initiation of foci of CMV-CPE, yet might be expected to prevent extracellular spread of CMV particles or antigenic viral components from initially infected to other uninfected cells in the culture. If interference was mediated by either of these means, then neutralizing antibody might prevent the establishment of interference. If, on the other hand, the postulated mediator was not antigenically related to CMV, the antibody should have no effect. The experimental protocol and result are schematically illustrated in Fig. 4 . CPE appeared both in CMV-infected cultures containing neutralizing antibody and in those cultures with equal concentration of human serum lacking anti-CMV activity. Although similar numbers of foci of CPE appeared, the spread of these foci was retarded in the presence of neutralizing antibody after 72 h of incubation. All three test groups of four plates each were then challenged with Sindbis virus and overlayed with agar plaque medium. Complete interference (O plaques) was established in both the CMVinfected sets of cultures compared with 100 plaques in the control HEF cultures exposed only to control human serum. These data strongly suggest that the initial foci of infected cells are sufficient to establish interference in the absence of further spread of CMV. This evidence further supports the hypothesis that a soluble, non-neutralizable mediator of interference is being produced by CMV-infected cells, and that the interference is not due to the physical presence of CMV particles in the cells manifesting interference.
To further test this hypothesis, a monolayer of HEF cells, infected with CMV, was scraped from a petri dish, centrifuged, washed three times, and placed in a sealed diffusion chamber (Millipore Corp.; 0.22 tim filters), which in turn was placed in a culture of HEF cells (group II) containing medium with CMV-neutralizing serum. Replicate groups of three plates infected with 0.2 ml of the CMV-infected cells served as the CMV-infected control (group I) or received similarly processed diffusion chambers containing NDV-infected cells (group IV) incubated in medium containing anti-NDV antibody. This latter control provided a virus-HEF system known to produce interferon. A set of uninfected plates (group III) served as a control. An outline of the protocol and results is summarized in Fig.  5 . All groups of plates were challenged with approximately 30 to 40 PFU of VSV. The average number of plaques observed in each group is also presented in Fig. 5 . Both the positive interferon control (group IV) and the cultures directly infected with CMV (group I) were completely protected. A striking degree of protection (88%) was also observed in the cultures with the diffusion chamber containing HEF cells infected with CMV (group II). On careful observation, no CPE could be found in the protected plates from group II. This would be expected if the neutralizing antibody (anti-CMV) prevented the dissemination of CMV from the diffusion chamber. The interference observed in a plate containing a diffusion chamber enclosing CMV-infected cells compared with a control HEF monolayer is illustrated in Fig. 6 .
These data strongly support the interpretation that a soluble mediator is responsible for the interference, and that it is not mediated by CMV particles or an antigenic component of CMV. If this conclusion is valid, it seems probable that an interferon-like substance was, in fact, the mediator of interference. The following experiment was designed to simulate the postulated mechanism of interference in the CMVinfected cultures.
To determine if the production of subdetectable levels of a known preparation of interferon could establish the observed pattern of interference, replicate groups of HEF cultures were maintained in the presence of 0.4 or 0.14 U of human interferon per ml, i.e., subdetectable levels of interferon. The medium from all culture plates was replaced with fresh medium containing 0.4 or 0.14 U of interferon or Eagle MEM per ml every 12 h to simulate continued production of low levels of interferon. Sets of three plates from each of the three groups were challenged with approximately 50 PFU of VSV 18, 48, and 72 h after the initial exposure to interferon. The results are illustrated in Fig. 7 . No viral interference was evidenced after 18 h of exposure at either level of interferon. In contrast, after 48 h and four media changes, 90 and 40% reduction in VSV plaques was observed in cultures exposed to interferon levels of 0.4 or 0.14 U/ml, respectively. By 72 h and two additional changes of medium, a further increase in inhibition, 100 and 60%, was observed in comparison with control cultures.
These data indicate that continued exposure of cells to subdetectable levels of interferon may establish a high level of interference in a population of cells.
Based on these results, a schematic illustration of the proposed explanation of CMV interference is presented in Fig. 8 (1, 2) . Replication of virus would probably be required to induce production of sufficient interferon to protect the remainder of the cell monolayer. The activity against heterologous viruses and the pattern of sensitivity of those viruses further supports this concept. The time required for production of interferon and for that interferon to establish the antiviral state would also be compatible with this hypothesis. The characteristic of being able to overcome interference with a high multiplicity of challenge virus is also supportive. Ho (4) has presented data that was interpreted to indicate that "protection of cells by interferon may be overcome in the presence of increasing virus multiplicity." The common observation that those plaques that form in interferontreated cultures will continue to increase in size provides additional support for this interpretation. The presence of interferon-like activity is also substantiated by the lack of effect on adsorption of virus to the HEF cells. Finally, the capacity to induce interference in a culture of HEF when CMV-infected cells are confined in a diffusion chamber suspended in medium containing anti-CMV antibody strongly suggests the presence of a soluble product of the CMV-HEF interaction that mediates the interference.
Evidence has previously been presented (3, 8) that suggests that CMV does not induce interferon. Interferon was not detectable, at least within the limitations of our human interferon assay system, in the medium harvested from cultures infected with CMV. Other evidence that must be reconciled with the present data is the previous report from our laboratory that CMV inhibited the induction of interferon by Chikungunya virus (CV). There are two possible explanations for that observation. First, different cell lines were utilized in the two sets of experiments (WI-38 and HEF). Secondly, the inhibition of interferon production after challenge with CV was observed 48 to 96 h after CMV infection. It has been previously shown that exposure to interferon preparations may either enhance or inhibit subsequent interferon production, depending upon the system being studied. It is possible, therefore, that the CMVinfected cultures become hyporeactive and that, even if the soluble mediator is interferon, further induction of additional interferon after challenge with CV could be suppressed.
The present report represents a second method by which CMV can induce interference. Marcus and Carver (5, 6) and Seto and Carver (9) have previously presented evidence that indicated that infection of WI-38 cells with CMV may result in intrinsic interference. The nature of the observed interference in this study is strikingly different from intrinsic interference: (i) the interference is effective not only against NDV, but also against six other viruses;
(ii) in intrinsic interference the refractory state is a property of the individual virus-infected cell, not of other uninfected cells in the culture; and (iii) there is no evidence of a soluble mediator of interference involved in intrinsic interference. These basic differences in the two systems suggest that CMV has the capacity to induce interference in an infected monolayer by two different mechanisms, intrinsic interference and induction of a soluble interferon-like mediator of interference. ACKNOWLEDGMENT This work was partially supported by Public Health Service grant AI-10217 from the National Institute of Allergy and Infectious Diseases.
